propranolol has been researched along with Endothelioma, Lymphatic in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akyüz, C | 1 |
Ataş, E | 1 |
Varan, A | 1 |
Spier, AB | 1 |
Kurtz, J | 1 |
Sears, D | 1 |
Ozeki, M | 2 |
Fukao, T | 2 |
Kondo, N | 2 |
Leboulanger, N | 1 |
Garel, C | 1 |
Borde, IT | 1 |
Garabedian, EN | 1 |
Denoyelle, F | 1 |
Esparza, EM | 1 |
Deutsch, G | 1 |
Stanescu, L | 1 |
Weinberger, E | 1 |
Brandling-Bennett, HA | 1 |
Sidbury, R | 1 |
Kanda, K | 1 |
Kawamoto, N | 1 |
Ohnishi, H | 1 |
Fujino, A | 1 |
Hirayama, M | 1 |
Kato, Z | 1 |
Azuma, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Melablock: A Multicentre Randomized, Double---blinded and Placebo---controlled Clinical Trial on the Efficacy and Safety of Once Daily Propranolol 80 mg Retard for the Prevention of Cutaneous Malignant Melanoma Recurrence[NCT02962947] | Phase 2/Phase 3 | 546 participants (Anticipated) | Interventional | 2017-06-30 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for propranolol and Endothelioma, Lymphatic
Article | Year |
---|---|
Propranolol as an alternative treatment option for pediatric lymphatic malformation.
Topics: Administration, Oral; Humans; Infant; Japan; Lymphangioma; Magnetic Resonance Imaging; Propranolol; | 2013 |
5 other studies available for propranolol and Endothelioma, Lymphatic
Article | Year |
---|---|
Treatment of a tongue lymphangioma with sirolimus after failure of surgical resection and propranolol.
Topics: Adrenergic beta-Antagonists; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Humans; | 2014 |
A novel case of lymphangiomatosis in HIV.
Topics: Antirheumatic Agents; Bevacizumab; Cell Proliferation; HIV Infections; Humans; Lung; Lymphangioma; L | 2017 |
Propranolol for intractable diffuse lymphangiomatosis.
Topics: Adolescent; Chylothorax; Humans; Lung; Lung Neoplasms; Lymphangioma; Male; Propranolol; Radiography; | 2011 |
Propranolol therapy for hemorrhagic lymphangioma of the tongue.
Topics: Adrenergic beta-Antagonists; Child; Child, Preschool; Female; Hemorrhage; Humans; Lymphangioma; Prop | 2011 |
Multifocal lymphangioendotheliomatosis with thrombocytopenia: phenotypic variant and course with propranolol, corticosteroids, and aminocaproic acid.
Topics: Aminocaproates; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Inf | 2012 |